WhizAI, a Somerset, NJ-based first and only augmented analytics platform purpose-built for the life sciences and healthcare industries, announced that it completed a new round of funding, bringing the total raised since launching in 2017 to $21 million.
The company received investment from strategic investors Shanda Group and AmerisourceBergen's AB Health Ventures, with participation from existing investors like Vertical Venture Partners and Healthy Ventures.
The new funding will be used to grow its footprint with new and existing top global pharma clients, develop new strategic alliances, and add to its leadership team, sales and marketing organization, engineering capacity, and product capabilities.
"WhizAI began with the vision to democratize business insights for life sciences and healthcare, ensuring analytics is for everyone. Our momentum in 2022 demonstrates that our vision and domain-centric approach is preferred by our clients," said Rohit Vashisht, Co-Founder and CEO of WhizAI. "We're excited to see how the market has responded to our vision for analytics to be augmented with artificial intelligence and natural language technology. With the support of AB Health Ventures and our other investors, such as Shanda Group, we're ready to take the next step in bringing actionable insights and, ultimately, greater agility, better decision-making, and cost savings to our clients' analytics ecosystem."
Earlier this year, Gartner named WhizAI in five different hype cycles for natural language query, AI in clinical development, and augmented analytics for life sciences.
Everest Group also recognized WhizAI as a "trailblazer" in their list of the "Top Seven Startups Creating a Buzz in the Life Sciences Commercial Technology Landscape: Life Sciences Commercial Analytics and AI Trailblazers."
Company: Whizdotai, Inc.
Funding Month: October 2022
Lead Investors: Shanda Group and AmerisourceBergen's AB Health Ventures
Additional Investors: Vertical Venture Partners and Healthy Ventures
Company Website: https://www.whiz.ai/
Software Category: AI-powered analytics platform
About the Company: WhizAI is an AI-powered analytics platform purpose-built for life sciences and healthcare. It puts insights directly into the hands of business users, empowering decision-makers to drive more informed and faster business decisions at lower costs. With its deep understanding of the life sciences and healthcare domains and user intent, the platform delivers insights without the delays of traditional BI dashboards. Fast, easy, and scalable, WhizAI is transforming analytics with artificial intelligence optimized for life sciences and healthcare, making WhizAI the trusted partner of choice at top global companies.